IL102310A - Pharmaceutical compositions comprising cyclosporins - Google Patents

Pharmaceutical compositions comprising cyclosporins

Info

Publication number
IL102310A
IL102310A IL102310A IL10231092A IL102310A IL 102310 A IL102310 A IL 102310A IL 102310 A IL102310 A IL 102310A IL 10231092 A IL10231092 A IL 10231092A IL 102310 A IL102310 A IL 102310A
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
cyclosporins
cyclosporin
glyceride
tri
Prior art date
Application number
IL102310A
Other languages
English (en)
Other versions
IL102310A0 (en
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10697415&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL102310(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sandoz Ag filed Critical Sandoz Ag
Priority to IL11854692A priority Critical patent/IL118546A/en
Publication of IL102310A0 publication Critical patent/IL102310A0/xx
Publication of IL102310A publication Critical patent/IL102310A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11C—FATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
    • C11C3/00—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom
    • C11C3/04—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by esterification of fats or fatty oils
    • C11C3/06—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by esterification of fats or fatty oils with glycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nanotechnology (AREA)
  • Medical Informatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Dispersion Chemistry (AREA)
  • Oncology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Transplantation (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fats And Perfumes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Confectionery (AREA)
IL102310A 1991-06-27 1992-06-25 Pharmaceutical compositions comprising cyclosporins IL102310A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL11854692A IL118546A (en) 1991-06-27 1992-06-25 Transesterified corn oil products

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919113872A GB9113872D0 (en) 1991-06-27 1991-06-27 Improvements in or relating to organic compounds

Publications (2)

Publication Number Publication Date
IL102310A0 IL102310A0 (en) 1993-01-14
IL102310A true IL102310A (en) 1997-03-18

Family

ID=10697415

Family Applications (3)

Application Number Title Priority Date Filing Date
IL11854692A IL118546A (en) 1991-06-27 1992-06-25 Transesterified corn oil products
IL102310A IL102310A (en) 1991-06-27 1992-06-25 Pharmaceutical compositions comprising cyclosporins
IL11854696A IL118546A0 (en) 1991-06-27 1996-06-03 Transesterified corn oil products

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IL11854692A IL118546A (en) 1991-06-27 1992-06-25 Transesterified corn oil products

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL11854696A IL118546A0 (en) 1991-06-27 1996-06-03 Transesterified corn oil products

Country Status (38)

Country Link
EP (2) EP0539319B1 (de)
JP (2) JP2653958B2 (de)
KR (3) KR0131064B1 (de)
CN (1) CN1077798C (de)
AT (1) AT403436B (de)
AU (1) AU659460B2 (de)
CA (2) CA2175842C (de)
CH (2) CH685764A5 (de)
CY (1) CY1906A (de)
CZ (1) CZ281790B6 (de)
DE (3) DE4244986B4 (de)
DK (2) DK0953630T3 (de)
EE (1) EE03108B1 (de)
ES (2) ES2142818T3 (de)
FI (2) FI109454B (de)
FR (2) FR2678169B1 (de)
GB (2) GB9113872D0 (de)
GR (1) GR3032366T3 (de)
HK (2) HK57196A (de)
HU (1) HU216792B (de)
IE (1) IE73662B1 (de)
IL (3) IL118546A (de)
IT (1) IT1254401B (de)
LU (1) LU88138A1 (de)
MX (1) MX9203236A (de)
MY (1) MY109512A (de)
NO (2) NO303964B1 (de)
NZ (1) NZ243309A (de)
PH (1) PH30337A (de)
PT (2) PT953630E (de)
RO (2) RO111021B1 (de)
RU (1) RU2143919C1 (de)
SA (1) SA92130213B1 (de)
SK (1) SK278759B6 (de)
TW (1) TW267943B (de)
UA (1) UA35559C2 (de)
UY (1) UY23864A1 (de)
ZA (1) ZA924719B (de)

Families Citing this family (79)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9113872D0 (en) * 1991-06-27 1991-08-14 Sandoz Ag Improvements in or relating to organic compounds
ES2168271T3 (es) 1992-09-25 2002-06-16 Novartis Ag Composiciones farmaceuticas que contienen ciclosporinas.
NZ247516A (en) * 1993-04-28 1995-02-24 Bernard Charles Sherman Water dispersible pharmaceutical compositions comprising drug dissolved in solvent system comprising at least one alcohol and at least one surfactant
AT408520B (de) * 1993-05-27 2001-12-27 Novartis Erfind Verwalt Gmbh Galenische formulierungen
GB2278780B (en) * 1993-05-27 1998-10-14 Sandoz Ltd Macrolide formulations
CH686761A5 (de) 1993-05-27 1996-06-28 Sandoz Ag Galenische Formulierungen.
DE4322826A1 (de) * 1993-07-08 1995-01-12 Galenik Labor Freiburg Gmbh Pharmazeutisches Präparat
ATE198041T1 (de) * 1993-09-28 2000-12-15 Scherer Gmbh R P Herstellung von weichgelatinekapseln
DE4340781C3 (de) * 1993-11-30 2000-01-27 Novartis Ag Cyclosporin enthaltende flüssige Zubereitungen und Verfahren zu ihrer Herstellung
US5891846A (en) * 1994-02-17 1999-04-06 Shiseido Company, Ltd. Cyclosporin-containing emulsion composition
EP0694308A4 (de) * 1994-02-17 1997-09-10 Shiseido Co Ltd Cyclosporin-enthaltene emulsionszusammensetzung
NZ270145A (en) * 1994-03-01 1996-08-27 Lilly Co Eli Non-aqueous pharmaceutical formulation for oral administration comprising water-insoluble active agent, fatty acid solubilising agent, an oil and a surface active agent
GB9405304D0 (en) * 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs
ES2133655T3 (es) * 1994-03-31 1999-09-16 Unilever Nv Aceites con bajo contenido de acidos grasos saturados.
IL115742A (en) * 1994-10-26 2000-06-01 Novartis Ag Pharmaceutical compositions comprising a difficultly soluble active agent a hydrophilic phase a lipophilic phase and a surfactant
GB2308545B (en) * 1994-10-26 1999-06-02 Novartis Ag Pharmaceutical microemulsion preconcentrates
PT789580E (pt) 1994-11-03 2002-09-30 Novartis Ag Formulacoes de ciclosporina para administracao oral com composicao simples e alta biodisponibilidade e processo para a sua producao
HU215966B (hu) * 1994-11-21 1999-07-28 BIOGAL Gyógyszergyár Rt. Orálisan alkalmazható, ciklosporint tartalmazó, összetett emulzió-előkoncentrátum
US6861053B1 (en) 1999-08-11 2005-03-01 Cedars-Sinai Medical Center Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
WO1996036330A2 (en) * 1995-05-17 1996-11-21 Cedars-Sinai Medical Center Compositions containing fatty acids for improving digestion and absorption in the small intestine
CA2220451A1 (en) * 1995-05-17 1996-11-21 Cedars-Sinai Medical Center Methods and compositions for improving digestion and absorption in the small intestine
US7048906B2 (en) 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
US6008228A (en) * 1995-06-06 1999-12-28 Hoffman-La Roche Inc. Pharmaceutical compositions containing proteinase inhibitors
US6696413B2 (en) * 1995-06-16 2004-02-24 Hexal Ag Pharmaceutical preparation with cyclosporin A
SE504582C2 (sv) * 1995-07-06 1997-03-10 Gs Dev Ab Cyklosporinkomposition baserad på en L2-fas
DE19544507B4 (de) 1995-11-29 2007-11-15 Novartis Ag Cyclosporin enthaltende Präparate
US5858401A (en) 1996-01-22 1999-01-12 Sidmak Laboratories, Inc. Pharmaceutical composition for cyclosporines
CN1104258C (zh) * 1996-05-29 2003-04-02 周德和 用于环孢霉素a的赋形剂
US5958876A (en) * 1996-06-19 1999-09-28 Novartis Ag Cyclosporin-containing pharmaceutical compositions
CZ292378B6 (cs) * 1996-06-19 2003-09-17 Novartis Ag Přípravek obsahující cyklosporin a způsob jeho přípravy
KR980008239A (ko) * 1996-07-26 1998-04-30 김충환 사이클로스포린-함유 약학적 조성물
FR2752732B1 (fr) * 1996-08-28 1998-11-20 Pf Medicament Forme galenique a liberation prolongee de milnacipran
ZA9711732B (en) 1996-12-31 1998-12-28 Quadrant Holdings Cambridge Methods and compositions for improvement bioavailability of bioactive agents for mucosal delivery
US6306434B1 (en) * 1997-02-12 2001-10-23 Chong Kun Dang Corp. Pharmaceutical composition comprising cyclosporin solid-state microemulsion
NZ337316A (en) * 1997-03-12 2001-06-29 Abbott Lab Hydrophilic binary systems comprising cyclosporine, hydrophilic phase and a surfactant for the administration of cyclosporine
CA2285983A1 (en) 1997-04-29 1998-11-05 Bernard Charles Sherman Emulsion preconcentrate comprising a cyclosporin and acetylated monoglyceride
NZ314702A (en) * 1997-04-29 1998-07-28 Bernard Charles Sherman Pharmaceutical composition comprising a cyclosporin in a solvent system of acetylated monoglycerides and a surfactant and optionally a hydrophilic solvent
GB2326337A (en) 1997-06-20 1998-12-23 Phares Pharma Holland Homogeneous lipid compositions for drug delivery
NZ502566A (en) 1997-07-29 2002-03-28 Upjohn Co Pharmaceutical composition for acidic lipophilic compounds in a form of a self-emulsifying formulation containing a pyranone and a basic amine
NZ502569A (en) * 1997-07-29 2002-05-31 Upjohn Co Self-emulsifying formulation for lipophilic compounds comprising a mixture of diglyceride and monoglyceride in a ratio of 9:1 to 6:4
BR9810866B1 (pt) * 1997-07-29 2010-07-13 composição farmacêutica em uma forma de formulação auto-emulsificante para compostos lipofìlicos.
US20030220234A1 (en) 1998-11-02 2003-11-27 Selvaraj Naicker Deuterated cyclosporine analogs and their use as immunodulating agents
WO1999019471A1 (en) 1997-10-16 1999-04-22 Board Of Regents, The University Of Texas System Models and treatments for cardiac hypertrophy in relation with nf-at3 function
CA2313024C (en) 1997-12-10 2008-06-03 Severson, Mary L. Pharmaceutical compositions containing an omega-3 fatty acid oil
ID25908A (id) * 1998-03-06 2000-11-09 Novartis Ag Prakonsentrat-prakonsentrat emulsi yang mengandung siklosporin atau makrolida
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
DE69822814T2 (de) * 1998-08-18 2005-01-27 Panacea Biotec Ltd. Zusammensetzung enthaltend Cyclosporin in einem hydrophilen Träger
CN1236813C (zh) * 1998-12-11 2006-01-18 药品处理公司 水难溶性药物的自乳化组合物
DE69939335D1 (de) 1998-12-30 2008-09-25 Dexcel Ltd Dispergierbares konzentrat zur verabreichung von cyclosporin
GB9903547D0 (en) 1999-02-16 1999-04-07 Novartis Ag Organic compounds
CN1167462C (zh) * 1999-03-09 2004-09-22 杭州华东医药集团生物工程研究所有限公司 一种含环孢素的药物组合物
US6956048B2 (en) 1999-03-31 2005-10-18 Pharmacia & Upjohn Company Pharmaceutical emulsions for retroviral protease inhibitors
WO2001032143A1 (en) * 1999-11-02 2001-05-10 Cipla Ltd. A pharmaceutical composition for the administration of water-insoluble pharmaceutically active substances and a process for preparation thereof
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
GB0008785D0 (en) 2000-04-10 2000-05-31 Novartis Ag Organic compounds
GB0019118D0 (en) * 2000-08-03 2000-09-27 Danisco Solid phase glycerolysis
BR0113108A (pt) 2000-08-08 2003-06-10 Kao Corp Composição de óleo/gordura
US7115565B2 (en) 2001-01-18 2006-10-03 Pharmacia & Upjohn Company Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability
AR033711A1 (es) * 2001-05-09 2004-01-07 Novartis Ag Composiciones farmaceuticas
US7141648B2 (en) 2001-10-19 2006-11-28 Isotechnika Inc. Synthesis of cyclosporin analogs
CA2461730C (en) 2001-10-19 2012-05-15 Isotechnika Inc. Novel cyclosporin analog microemulsion preconcentrates
KR100441167B1 (ko) * 2001-12-27 2004-07-21 씨제이 주식회사 마이크로에멀젼 예비 농축액 조성물
KR100525234B1 (ko) * 2003-02-19 2005-10-28 한국유나이티드제약 주식회사 사이클로스포린 함유 연질캅셀제 및 그 제조방법
GT200500310A (es) * 2004-11-19 2006-06-19 Compuestos organicos
GB0504950D0 (en) 2005-03-10 2005-04-20 Novartis Ag Organic compositions
JP4889262B2 (ja) * 2005-08-19 2012-03-07 理研ビタミン株式会社 脂溶性薬剤組成物
MD3347G2 (ro) * 2006-12-26 2008-01-31 Институт Сельскохозяйственной Техники "Mecagro" Procedeu de obţinere a esterilor metilici din ulei de rapiţă
ITPD20070049A1 (it) * 2007-02-14 2008-08-15 Sila S R L Prodotto a base di acido linoleico coniugato e processo per la sua fabbricazione
WO2008122965A2 (en) 2007-04-04 2008-10-16 Sigmoid Pharma Limited Pharmaceutical cyclosporin compositions
CN101199836B (zh) * 2007-11-07 2011-03-30 安徽省药物研究所 一种阶段释放型环孢素a固体微乳制剂及其微乳固化方法
WO2010133609A2 (en) 2009-05-18 2010-11-25 Sigmoid Pharma Limited Composition comprising oil drops
US9878036B2 (en) 2009-08-12 2018-01-30 Sigmoid Pharma Limited Immunomodulatory compositions comprising a polymer matrix and an oil phase
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
JO3337B1 (ar) 2010-12-13 2019-03-13 Debiopharm Sa تركيبات صيدلية تشمل أليسبوريفير
FR2971941B1 (fr) 2011-02-24 2013-08-02 Physica Pharma Compositions pharmaceutiques administrables par voie cutanee et destinees au traitement local de la dermatite atopique canine
GB201304662D0 (en) 2013-03-14 2013-05-01 Sigmoid Pharma Ltd Compositions
AU2015341695B2 (en) 2014-11-07 2021-07-08 Sublimity Therapeutics Limited Compositions comprising cyclosporin
WO2020050182A1 (ja) * 2018-09-06 2020-03-12 株式会社カマタ カプセル充填用液状組成物及びカプセル剤
FI3886813T3 (fi) * 2018-11-26 2023-05-04 Hepion Pharmaceuticals Inc Syklosporiinianalogien farmaseuttisia formulaatioita

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1274354A (fr) * 1956-03-10 1961-10-27 Agents tensio-actifs obtenus à partir de triglycérides et polyéthylène glycol
FR2344283A1 (fr) * 1976-03-17 1977-10-14 Gattefosse Ets Sa Nouveau melange de glycerides utile comme nutriment lipidique
SE445174B (sv) * 1978-03-07 1986-06-09 Sandoz Ag Farmaceutisk komposition innehallande en cyklosporin och en berarsubstans
CH641356A5 (en) * 1979-02-27 1984-02-29 Sandoz Ag Pharmaceutical compositions containing cyclosporin
AU558155B2 (en) * 1982-02-01 1987-01-22 Sandoz Ltd. Treating multiple sclerosis with dihydro-cyclosporin d
GB8903804D0 (en) * 1989-02-20 1989-04-05 Sandoz Ltd Improvements in or relating to organic compounds
DE3444893A1 (de) * 1984-12-08 1986-06-12 Henkel KGaA, 4000 Düsseldorf Verfahren zur herstellung von fettsaeuremethylestern
JPS62201591A (ja) * 1986-02-28 1987-09-05 Shoichi Shimizu 油脂のグリセロリシス法
JP2632010B2 (ja) * 1988-01-29 1997-07-16 三共株式会社 シクロスポリン製剤
CH679119A5 (de) * 1988-05-13 1991-12-31 Sandoz Ag
HU201567B (en) * 1988-07-21 1990-11-28 Gyogyszerkutato Intezet Process for production of intravenous medical compositions containing cyclosphorin
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
GB8823621D0 (en) * 1988-10-07 1988-11-16 Madhok R Compositions containing cyclosporins
JPH0738771B2 (ja) * 1989-01-17 1995-05-01 花王株式会社 液状食用油組成物
FR2642650B1 (fr) * 1989-02-09 1994-12-09 Sandoz Sa Nouvelles compositions pharmaceutiques a base de cyclosporines
AU6785490A (en) * 1989-12-18 1991-06-20 Kraft General Foods, Inc. Low-saturate edible oils and transesterification methods for production thereof
GB9113872D0 (en) * 1991-06-27 1991-08-14 Sandoz Ag Improvements in or relating to organic compounds

Also Published As

Publication number Publication date
MY109512A (en) 1997-02-28
UA35559C2 (uk) 2001-04-16
GB2257359A (en) 1993-01-13
DE4244986B4 (de) 2008-07-24
IL102310A0 (en) 1993-01-14
DE4219526A1 (de) 1993-03-18
MX9203236A (es) 1992-12-01
SA92130213B1 (ar) 2004-07-24
NO922506D0 (no) 1992-06-25
DE4219526C2 (de) 1999-04-22
CN1077798C (zh) 2002-01-16
HK57196A (en) 1996-04-12
FR2678169B1 (fr) 1994-08-26
FI922958A0 (fi) 1992-06-25
EP0539319B1 (de) 1999-12-08
HK157696A (en) 1996-08-30
CH684163A5 (de) 1994-07-29
LU88138A1 (fr) 1994-03-01
TW267943B (de) 1996-01-11
FR2685706B1 (de) 1994-12-23
JPH09118894A (ja) 1997-05-06
NO922506L (no) 1992-12-28
EE03108B1 (et) 1998-08-17
CA2175842C (en) 2002-05-07
ZA924719B (en) 1993-12-27
RO111110B1 (ro) 1996-06-28
DE4244930C2 (de) 1999-11-11
HU9201975D0 (en) 1992-09-28
PT953630E (pt) 2004-11-30
FI109454B (fi) 2002-08-15
CN1079907A (zh) 1993-12-29
ES2142818T3 (es) 2000-05-01
ES2227921T3 (es) 2005-04-01
JPH05186365A (ja) 1993-07-27
CA2072509A1 (en) 1992-12-28
PH30337A (en) 1997-04-02
IL118546A (en) 1998-09-24
CZ281790B6 (cs) 1997-01-15
IL118546A0 (en) 1996-10-16
EP0953630A1 (de) 1999-11-03
AU1852792A (en) 1993-03-11
NZ243309A (en) 1995-02-24
EP0539319A2 (de) 1993-04-28
GR3032366T3 (en) 2000-04-27
HU216792B (hu) 1999-08-30
NO303964B1 (no) 1998-10-05
ATA129892A (de) 1997-07-15
FI922958L (fi) 1992-12-28
FR2678169A1 (fr) 1992-12-31
CZ197792A3 (en) 1993-01-13
IE73662B1 (en) 1997-06-18
FI116199B (fi) 2005-10-14
JP2653958B2 (ja) 1997-09-17
GB2257359B (en) 1996-01-10
UY23864A1 (es) 1995-05-29
SK278759B6 (sk) 1998-02-04
KR930000113A (ko) 1993-01-15
NO325267B1 (no) 2008-03-17
RO111021B1 (ro) 1996-06-28
DK0953630T3 (da) 2004-11-01
GB9213393D0 (en) 1992-08-05
ITRM920476A1 (it) 1993-12-23
CA2175842A1 (en) 1992-12-28
AT403436B (de) 1998-02-25
KR0131064B1 (ko) 1998-04-17
FI961513L (fi) 1996-04-03
PT539319E (pt) 2000-05-31
NO964382D0 (no) 1996-10-15
RU2143919C1 (ru) 2000-01-10
CA2072509C (en) 1996-07-30
IT1254401B (it) 1995-09-14
HUT62201A (en) 1993-04-28
FR2685706A1 (fr) 1993-07-02
NO964382L (no) 1992-12-28
KR100231384B1 (en) 1999-11-15
EP0539319A3 (en) 1993-06-09
DK0539319T3 (da) 2000-05-22
FI961513A0 (fi) 1996-04-03
KR100231385B1 (en) 1999-11-15
SK197792A3 (en) 1994-03-09
AU659460B2 (en) 1995-05-18
CH685764A5 (de) 1995-09-29
CY1906A (en) 1992-06-24
JP3420897B2 (ja) 2003-06-30
IE922082A1 (en) 1992-12-30
ITRM920476A0 (it) 1992-06-23
GB9113872D0 (en) 1991-08-14
EP0953630B1 (de) 2004-09-08

Similar Documents

Publication Publication Date Title
IL102310A (en) Pharmaceutical compositions comprising cyclosporins
HK86593A (en) Pharmaceutical compositions containing cyclosporins
PL335575A1 (en) Hydrophilic two-component systems for use in administration of cyclosporine
DK0588539T3 (da) Stabiliserede farmaceutiske præparater indeholdende derivater af vitamin D2 og D3
CA2274485A1 (en) Medicinal composition
EP0995434A3 (de) Medizinische Aerosolformulierungen
EP0948965A4 (de) Stabile medizinische zusammenstellungen die 4,5-epoxymorphinanderivate enthalten
AR013499A1 (es) Composiciones solidas que comprenden un polipeptido ciclosporina y un surfactante anionico
SI0984982T1 (en) Lh-rh peptide analogues, their uses and pharmaceutical compositions containing them
BG103425A (en) Pharmaceutical composition
IL126447A0 (en) A composition for the prevention and/or treatment of atherosclerosis
GB2367004A (en) Pharmaceutical compositions
AU587307B2 (en) Verapamil dosage form
IT1243193B (it) Composizioni farmaceutiche orali a base di melatonina
FR2678167B1 (fr) Preparations ophtalmiques a liberation prolongee.
DE69532809D1 (de) Pharmazeutische präparate, insbesondere ovula, die viele verschiedene aktive bestandteile enthalten
ES2133152T3 (es) Composicion de tiotepa liofilizada estable.
AU3777197A (en) Cyclosporin formulation
CA2185883A1 (en) The use of dimeticone as a transport and carrier system and/or drug delivery system
CA2113274A1 (en) Hops-derived foam stability and bittering agents isomerized-.alpha.-acids
ZA9710254B (en) LH-RH peptide analogues, their uses and pharmaceutical composition containing them.
GR3002420T3 (en) Medicinal formulation
GB2265791B (en) Including missing parties in active trunked group calls
ES2111755T3 (es) Combinaciones antiviricas.
GR900100542A (en) Dispenser comprising ionophore

Legal Events

Date Code Title Description
FF Patent granted
HC Change of name of proprietor(s)
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired